Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIa Clinical Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps

NCT07174115 is registered in ClinicalTrials.gov with Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. as lead sponsor.

NCT NCT07174115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07174115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIa Clinical Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps
Lead sponsor
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Phase
Phase 2
Overall status
Recruiting
Start date
August 18, 2025
Completion date
June 30, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic sinusitis without nasal polyps